Product NewsDrug discovery > Pre-Clinical Development
CRS model platform
6 Feb 2024
In this video, The Jackson Laboratory presents novel humanized mouse models for cytokine release syndrome (CRS), enabling simultaneous testing of immunotoxicity and drug efficacy. The models allow testing of candidate therapies with or without a tumor present, utilizing a variety of donors.
About the company
The Jackson Laboratory
The Jackson Laboratory is a global leader in preclinical studies and has been driving therapeutic development breakthroughs for over 90 years. With the most innovative preclinical platforms including humanized mice, and services such as dose ranging, toxicity, and efficacy studies, JAX empowers drug developers and researchers worldwide.
